James Zangrilli

Follow

Person

Philadelphia, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Use of reslizumab to treat moderate to severe eosinophilic asthma
- Patent number 9,815,894
- Issue date Nov 14, 2017
- Cephalon, Inc.
- Christopher O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Inhalation Systems, Devices and Methods
- Publication number 20180056018
- Publication date Mar 1, 2018
- Cephalon, Inc.
- Janice M.G. Canvin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Reslizumab to Treat Moderate to Severe Eosinophilic Asthma
- Publication number 20180030131
- Publication date Feb 1, 2018
- Cephalon, Inc.
- Christopher Obrien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Reslizumab To Treat Moderate to Severe Eosinophilic Asthma
- Publication number 20160102144
- Publication date Apr 14, 2016
- Christopher O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE